Dynapenia in digestive cancer outpatients: association with markers of functional and nutritional status (the FIGHTDIGO study).
Marine PerrierMarie-Amelie OrdanCoralie BarbeCamille MazzaDamien BotsenJohanna MoreauYohann RenardMathilde BrasseurBarbara TaillierePhilippe RegnaultEric BertinOlivier BouchePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Identification of dynapenia using HGS measurement may be useful to predict nutritional vulnerability in digestive cancer outpatients undergoing chemotherapy. Patients could then benefit from nutritional support, adapted physical activity programs, and early therapeutic adjustments. Trial registration ClinicalTrials.gov, NCT02797197.
Keyphrases
- papillary thyroid
- physical activity
- end stage renal disease
- squamous cell
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- climate change
- prognostic factors
- public health
- body mass index
- study protocol
- peritoneal dialysis
- childhood cancer
- phase iii
- patient reported outcomes
- young adults
- phase ii
- radiation therapy
- open label
- rectal cancer